PMID 27630114
Clinical Judgment : Monitoring decisions should be individualized based on the balance of fracture risk factors, expected weight loss, treatment duration, and patient preferences
Several approaches have been described, including the use of natural albumin-binding proteins such as antibody fragments binding to serum albumin 22,23,24 , albumin-binding peptides 25 , the streptococcal protein G-derived albumin-binding domain 26,27 , and serum albumin-binding DARPin 28
However, in murine models, exendin-4 demonstrates about 5,500-fold greater potency in improving glucose control, evidenced by the percentage fall in plasma glucose at 1 hour (87)
Stopping GLP-1 Medications Before Surgery The American Society of Anesthesiologists recommends specific protocols for discontinuing GLP-1 medications before elective surgery
designed and expressed four injectable long-acting GLP-1R agonists in a bacterial expression system by genetically fusing Exendin-4 to the N-terminus of HSA-binding DARPin via linkers of different types and lengths